West Pharmaceutical Services, Inc. (NYSE: WST) last traded at $371.82, up 1.15% on the session. The quote above updates while this page is open; the figures below are drawn from West Pharmaceutical Services, Inc.’s own filings and are restated only when a new one is published.
West Pharmaceutical Services, Inc. trades on NYSE under the ticker WST. Its market capitalisation is $26.17 billion.
Valuation measures for West Pharmaceutical Services, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $26.17B |
|---|---|
| Enterprise value | $26.82B |
| P/E ratio | 47.61 |
| Price / sales | 7.87 |
| Price / book | 8.75 |
| Beta | 0.61 |
Trailing-twelve-month figures tagged in West Pharmaceutical Services, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $3.33B |
|---|---|
| Net income (TTM) | $564.90M |
| EPS (TTM) | $7.81 |
| Gross margin | 36.79% |
| Operating margin | 20.45% |
| Return on equity | 18.89% |
| Cash | $435.80M |
Range and volume for WST over the past 52 weeks.
| 52-week high | $386.00 |
|---|---|
| 52-week low | $223.83 |
| Volume | 507.5K |
| Average volume | 620.6K |
| Previous close | $367.60 |
Dividend history for West Pharmaceutical Services, Inc. over the trailing twelve months.
| Dividend yield | 0.23% |
|---|---|
| Dividend per share (TTM) | $0.870 |
| Payout ratio | 11.14% |
Invest a chosen dollar amount in West Pharmaceutical Services, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell WST.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.